Jeff Baxter is CEO & President at VBI Vaccines Inc/BC (VBIV). They have made 11 open-market trades across 1 company since 2017, most recently 2019-09-30.
CIK 0001615941
11 open-market purchases totalling $490K since 2017, never a sale. Across 11 scored buys the stock is up 9.7% at ninety days, and 7.4 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VBIV | 608,255 | $40K |
Shares reported on the most recent Form 4, priced at the 2019-09-30 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 36% | 73% | 45% |
| Avg Move | +0.3% | +7.3% | +9.7% |
| Alpha | +0.1% | +5.5% | +7.4% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VBIV | BUY | 2019-09-30 | 2019-09-30 | $0.50 | $75K | +5.8% | +14.4% | +161.9% |
| VBIV | BUY | 2019-06-19 | 2019-06-19 | $0.73 | $105K | +32.9% | +1.8% | -8.6% |
| VBIV | BUY | 2018-08-06 | 2018-08-07 | $1.93 | $16K | -3.1% | +16.5% | +15.5% |
| VBIV | BUY | 2018-08-03 | 2018-08-06 | $2.01 | $27K | -1.0% | +11.3% | +14.9% |
| VBIV | BUY | 2018-07-31 | 2018-08-01 | $2.28 | $38K | -12.5% | -1.9% | -21.2% |
| VBIV | BUY | 2018-05-24 | 2018-05-25 | $2.99 | $33K | -1.3% | -5.8% | -39.6% |
| VBIV | BUY | 2018-05-11 | 2018-05-14 | $2.91 | $21K | -7.4% | +19.2% | -43.7% |
| VBIV | BUY | 2017-12-12 | 2017-12-13 | $3.89 | $39K | +6.0% | +6.2% | -6.2% |
| VBIV | BUY | 2017-11-28 | 2017-11-29 | $4.75 | $71K | -16.3% | -10.7% | -22.6% |
| VBIV | BUY | 2017-08-21 | 2017-08-22 | $3.22 | $32K | +5.9% | +20.1% | +39.5% |
| VBIV | BUY | 2017-08-10 | 2017-08-14 | $3.28 | $33K | -5.3% | +9.4% | +16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.